Celldex Therapeutics, Inc. — Director's Dealing 2018

Dec 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2018-12-03

Reporting Person: McMahon Gerald PhD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-03	Common Stock, par value $0.001	F	2824	$.2986	Disposed	180697	Direct

Footnotes

F1: On November 28, 2016, in connection with the Reporting Person's employment severance agreement the ("Severance Agreement") with Celldex Therapeutics, Inc. ("Issuer") whereby Issuer agreed to pay Reporting Person 267,356 shares of its common stock, par value $0.001 per share ("Common Stock") less required tax and other withholdings ("Withholdings".) The Reporting Person previously reported ownership of such 267,356 shares on his Form 3 filed with the Securities and Exchange Commission on December 15, 2016. The shares, less Withholdings, are issuable to Reporting Person in equal installments through December 2018.

F2: Pursuant to the Severance Agreement, on December 3, 2018, the Issuer issued 5,343 shares of its Common Stock to the Reporting Person. This Form 4 reflects the disposition to the Issuer of 2,824 shares of its Common Stock to satisfy required Withholdings in connection with such issuance of its Common Stock to the Reporting Person.